Sorrento continues slide, down 13% [Seeking Alpha]
Sorrento Therapeutics, Inc. (SRNE)
Last sorrento therapeutics, inc. earnings: 8/9 04:49 pm
Check Earnings Report
US:NASDAQ Investor Relations:
sorrentotherapeutics.com/investors
Company Research
Source: Seeking Alpha
Sorrento Therapeutics ( SRNE ) slumps on almost 30% higher volume. Shares have lost almost half their value since mid-May. Earlier this week, majority-owned subsidiary Scilex Pharmaceuticals completed what appears to be a very expensive debt deal to fund the commercial launch of pain patch ZTlido (lidocaine topical system) for post-herpetic neuralgia. Scilex sold $244M of senior secured note due 2026 for an aggregate purchase price of $140M, but will net only $89.3M. In addition, note holders will receive 10 - 25% of net sales of ZTlido depending on certain circumstances. Also, if ZTlido sales fail to hit 95% of a predetermined target, it will have to increase the aggregate principal amount of the notes by $28M. See all stocks on the move » Now read: Long-Term Outlook For Crispr Therapeutics: Sept. 5, 2018 » Subscribe for full text news in your inbox
Show less
Read more
Impact Snapshot
Event Time:
SRNE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRNE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRNE alerts
High impacting Sorrento Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics